Literature DB >> 12946435

T cell proliferative responses to malondialdehyde-acetaldehyde haptenated protein are scavenger receptor mediated.

Monte S Willis1, Geoffrey M Thiele, Dean J Tuma, Lynell W Klassen.   

Abstract

Malondialdehyde-acetaldehyde (MAA) haptenated proteins have been described in disease processes related to prolonged oxidative stress (via malondialdehyde production), such as alcohol liver disease (ALD), non-alcoholic non-steatohepatitis (NASH) and atherosclerosis. Experimentally, high titer IgG1 antibody responses are seen after immunization without adjuvant; however, T cell proliferative responses and the role of scavenger receptors in this immunogenicity has not previously been described. In this study, T cell proliferative responses to the carrier protein, but not the MAA hapten itself, were identified in vitro. Moreover, these T proliferative responses were inhibited when MAA-hen egg lysozyme (HEL) was co-immunized with excess scavenger receptor ligand polyG (poly-guanylic acid), implicating the role of (a) scavenger receptor(s) in initiating the T helper cell response. Activated B cells were unable to process and present MAA-HEL preferentially to T cells, while thioglycollate-elicited (but not Con A-elicited) macrophages and dendritic cells (DC) did so with approximately 32-fold less MAA-HEL than native antigen necessary to initiate equal proliferative responses. While this preferential processing and presentation may be related to several factors, preferential binding of MAA haptenated proteins mediated by scavenger receptors may be one mechanism. IL-4 was absent from the supernatants of T proliferative assays despite a strong IgG1 response in vivo, although the TH2 cytokines IL-6 and IL-10 were expressed. Since the modification of proteins by the MAA have previously been shown to occur after ethanol consumption in vivo, the ability of MAA haptens to experimentally enhance immune responses, specifically humoral and T cell responses, may represent mechanisms by which autoimmune phenomena found in ALD occur.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12946435     DOI: 10.1016/S1567-5769(03)00136-X

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  15 in total

1.  Autoimmune hepatitis induced by syngeneic liver cytosolic proteins biotransformed by alcohol metabolites.

Authors:  Geoffrey M Thiele; Michael J Duryee; Monte S Willis; Dean J Tuma; Stanley J Radio; Carlos D Hunter; Courtney S Schaffert; Lynell W Klassen
Journal:  Alcohol Clin Exp Res       Date:  2010-09-22       Impact factor: 3.455

Review 2.  Immunological response in alcoholic liver disease.

Authors:  Michael J Duryee; Lynell W Klassen; Geoffrey M Thiele
Journal:  World J Gastroenterol       Date:  2007-10-07       Impact factor: 5.742

3.  Coexposure to mercury increases immunotoxicity of trichloroethylene.

Authors:  Kathleen M Gilbert; Benjamin Rowley; Horacio Gomez-Acevedo; Sarah J Blossom
Journal:  Toxicol Sci       Date:  2010-11-17       Impact factor: 4.849

4.  Malondialdehyde-acetaldehyde adducts and anti-malondialdehyde-acetaldehyde antibodies in rheumatoid arthritis.

Authors:  Geoffrey M Thiele; Michael J Duryee; Daniel R Anderson; Lynell W Klassen; Stephen M Mohring; Kathleen A Young; Dathe Benissan-Messan; Harlan Sayles; Anand Dusad; Carlos D Hunter; Jeremy Sokolove; William H Robinson; James R O'Dell; Anthony P Nicholas; Dean J Tuma; Ted R Mikuls
Journal:  Arthritis Rheumatol       Date:  2015-03       Impact factor: 10.995

5.  Malondialdehyde-acetaldehyde adduct is the dominant epitope after MDA modification of proteins in atherosclerosis.

Authors:  Michael J Duryee; Lynell W Klassen; Courtney S Schaffert; Dean J Tuma; Carlos D Hunter; Robert P Garvin; Daniel R Anderson; Geoffrey M Thiele
Journal:  Free Radic Biol Med       Date:  2010-08-06       Impact factor: 7.376

6.  Immunogenic and inflammatory responses to citrullinated proteins are enhanced following modification with malondialdehyde-acetaldehyde adducts.

Authors:  Geoffrey M Thiele; Michael J Duryee; Carlos D Hunter; Bryant R England; Benjamin S Fletcher; Eric C Daubach; Taylor P Pospisil; Lynell W Klassen; Ted R Mikuls
Journal:  Int Immunopharmacol       Date:  2020-03-27       Impact factor: 4.932

7.  Increased immunogenicity to P815 cells modified with malondialdehyde and acetaldehyde.

Authors:  Michael J Duryee; Lynell W Klassen; Bonnie L Jones; Monte S Willis; Dean J Tuma; Geoffrey M Thiele
Journal:  Int Immunopharmacol       Date:  2008-04-28       Impact factor: 4.932

Review 8.  Acetaldehyde adducts in alcoholic liver disease.

Authors:  Mashiko Setshedi; Jack R Wands; Suzanne M de la Monte
Journal:  Oxid Med Cell Longev       Date:  2010 May-Jun       Impact factor: 6.543

9.  PyTMs: a useful PyMOL plugin for modeling common post-translational modifications.

Authors:  Andreas Warnecke; Tatyana Sandalova; Adnane Achour; Robert A Harris
Journal:  BMC Bioinformatics       Date:  2014-11-28       Impact factor: 3.169

10.  Unique antibody responses to malondialdehyde-acetaldehyde (MAA)-protein adducts predict coronary artery disease.

Authors:  Daniel R Anderson; Michael J Duryee; Scott W Shurmur; John Y Um; Walter D Bussey; Carlos D Hunter; Robert P Garvin; Harlan R Sayles; Ted R Mikuls; Lynell W Klassen; Geoffrey M Thiele
Journal:  PLoS One       Date:  2014-09-11       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.